Ionis Pharmaceuticals, Inc. (IONS): Price and Financial Metrics

IONS POWR Grades

• Quality is the dimension where IONS ranks best; there it ranks ahead of 81.96% of US stocks.
• The strongest trend for IONS is in Quality, which has been heading down over the past 178 days.
• IONS ranks lowest in Momentum; there it ranks in the 9th percentile.

IONS Stock Summary

• Of note is the ratio of IONIS PHARMACEUTICALS INC's sales and general administrative expense to its total operating expenses; merely 5.78% of US stocks have a lower such ratio.
• Over the past twelve months, IONS has reported earnings growth of 1,162%, putting it ahead of 98.37% of US stocks in our set.
• Revenue growth over the past 12 months for IONIS PHARMACEUTICALS INC comes in at -27.53%, a number that bests just 7.24% of the US stocks we're tracking.
• If you're looking for stocks that are quantitatively similar to IONIS PHARMACEUTICALS INC, a group of peers worth examining would be RVMD, NRIX, XBIT, ABUS, and HGEN.
• Visit IONS's SEC page to see the company's official filings. To visit the company's web site, go to www.ionispharma.com.

IONS Valuation Summary

• IONS's price/earnings ratio is -18.6; this is 182.3% lower than that of the median Healthcare stock.
• Over the past 243 months, IONS's price/sales ratio has gone up 6.5.

Below are key valuation metrics over time for IONS.

IONS Growth Metrics

Its 2 year price growth rate is now at -29.96%.
• Its year over year price growth rate is now at -0.78%.
• Its 3 year cash and equivalents growth rate is now at 44.36%.

IONS's revenue has moved down $371,386,000 over the prior 34 months.

The table below shows IONS's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	587.367	-274.37	-269.722
2022-09-30	875.483	129.512	7.321
2022-06-30	848.809	98.367	-28.153
2022-03-31	840.768	53.811	-3.893
2021-12-31	810.456	30.799	-28.597
2021-09-30	660.731	-74.911	-593.481

IONS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• IONS has a Quality Grade of C, ranking ahead of 48.06% of graded US stocks.
• IONS's asset turnover comes in at 0.277 -- ranking 161st of 682 Pharmaceutical Products stocks.
• EDIT, MYMD, and VSTM are the stocks whose asset turnover ratios are most correlated with IONS.

The table below shows IONS's key quality metrics over time.